Angi's List | ANGI | Long at $2.00
The historical simple moving average (SMA) I've selected for Angi Inc 
ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled "soon". 70M float, 12% short interest...
Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency.
Thus at $2.00,ANGI is in a personal buy zone.
Target #1 = $2.25
Target #2 = $2.50
Target #3 = $3.00
Target #4 = $3.50
Target #5 = $3.70
ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled "soon". 70M float, 12% short interest...Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency.
Thus at $2.00,
ANGI is in a personal buy zone.Target #1 = $2.25
Target #2 = $2.50
Target #3 = $3.00
Target #4 = $3.50
Target #5 = $3.70
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。